Holen Sie sich die Stockscreener-App
1.72
17.01%
0.25
Handel nachbörslich:
1.72
Schlusskurs vom Vortag:
$1.47
Offen:
$1.52
24-Stunden-Volumen:
596.74K
Relative Volume:
3.94
Marktkapitalisierung:
$7.87M
Einnahmen:
$895.50K
Nettoeinkommen (Verlust:
$-26.30M
KGV:
-1.0488
EPS:
-1.64
Netto-Cashflow:
$-23.84M
1W Leistung:
+17.01%
1M Leistung:
-10.42%
6M Leistung:
-73.66%
1J Leistung:
-87.71%
1-Tages-Spanne:
$1.5175
$1.76
1-Wochen-Bereich:
$1.41
$1.76
52-Wochen-Spanne:
$1.30
$18.40
Mainz Biomed N V Stock (MYNZ) Company Profile
Firmenname
Mainz Biomed N V
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MYNZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
1.72 | 6.73M | 895.50K | -26.30M | -23.84M | -1.64 |
|
TMO
Thermo Fisher Scientific Inc
|
484.79 | 180.28B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
209.14 | 147.31B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
663.92 | 52.18B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
120.29 | 33.33B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.23 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-14 | Eingeleitet | Maxim Group | Buy |
| 2024-11-25 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Mainz Biomed N V Aktie (MYNZ) Neueste Nachrichten
Mainz Biomed Wins Swiss Regulatory Approval for Colorectal Cancer Screening Test - MarketScreener
Mainz Biomed’s colorectal cancer test receives Swiss regulatory approval By Investing.com - Investing.com South Africa
Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert® - Yahoo Finance
Mainz Biomed Secures $3 Million Through Securities Purchase Agreement - The Globe and Mail
Mainz Biomed Secures $3 Million in Funding Through Securities Purchase Agreement - AInvest
Mainz Biomed Prices $3 million Follow-on Offering at $1.35 per Unit - MarketScreener
Mainz Biomed raises $3M in follow-on offering. - AInvest
Mainz Biomed Prices $3.0M Follow-On Offering of Over 2.2M Units Including Ordinary Shares and Series A Warrants - 富途牛牛
Mainz Biomed Raises $3M in Follow-On Offering, Expects to Close on August 5 - AInvest
Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants - GlobeNewswire
Cancer Detection Biotech Mainz Biomed Secures $3.0M Funding to Advance Early Detection Programs - Stock Titan
What is Mainz Biomed N.V. company’s growth strategySuperior portfolio returns - Jammu Links News
Should I hold or sell Mainz Biomed N.V. stock in 2025Achieve rapid capital gains with smart investing - Jammu Links News
Is Mainz Biomed N.V. stock overvalued or undervaluedGet alerts on high-potential market moves - Jammu Links News
What institutional investors are buying Mainz Biomed N.V. stockGet real-time updates on market movers - Jammu Links News
What is the risk reward ratio of investing in Mainz Biomed N.V. stockSkyrocketing returns - Jammu Links News
Why is Mainz Biomed N.V. stock attracting strong analyst attentionBuild wealth steadily with proven investment strategies - Jammu Links News
How does Mainz Biomed N.V. compare to its industry peersGet alerts on the hottest market movers - Jammu Links News
What is the dividend policy of Mainz Biomed N.V. stockRapid return acceleration - Jammu Links News
Does Mainz Biomed N.V. stock perform well during market downturnsTremendous return on equity - Jammu Links News
How strong is Mainz Biomed N.V. company’s balance sheetUnprecedented growth rates - Jammu Links News
What catalysts could drive Mainz Biomed N.V. stock higher in 2025Capitalize on market trends with confidence - Jammu Links News
How many analysts rate Mainz Biomed N.V. as a “Buy”Advanced Screener Planner For 2025 - Jammu Links News
Mainz Biomed Announces Sale of 1.47 Million Ordinary Units to Bolster Financial Position and Support Growth Initiatives - AInvest
What are Mainz Biomed N.V. company’s key revenue driversDaily Trading Outlook With Proven Results - Jammu Links News
Chartists See Breakout Potential in Mainz Biomed N.V.Real Trader Watchlist of Hot Stocks Released - metal.it
Why Mainz Biomed N.V. stock attracts strong analyst attentionROI Boosting Trade Opportunity Calendar Published - metal.it
What are the technical indicators suggesting about Mainz Biomed N.V.Stay ahead with advanced stock screening tools - Jammu Links News
What institutions are buying Mainz Biomed N.V. stock nowFree Stock Market Beginners Guide - metal.it
Mainz Biomed N.V. Stock Analysis and ForecastStrong return on assets - Jammu Links News
Does Mainz Biomed N.V. stock pay reliable dividendsRapid capital growth - Jammu Links News
Should I buy Mainz Biomed N.V. stock before earningsHigh-impact stock picks - Jammu Links News
What drives Mainz Biomed N.V. stock priceUnprecedented market success - Autocar Professional
Finanzdaten der Mainz Biomed N V-Aktie (MYNZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.96%
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):